Generics Bulletin Editor’s Picks For Q4 2022
Highlights Across The Off-Patent Sector From October To December 2022
Executive Summary
Looking back over the fourth quarter of 2022, Generics Bulletin executive editor Dave Wallace picks out highlights from October to December that include a leadership change for one of the top industry players, some key developments for biosimilars and the announcement of the winners of our annual awards.